GoodRx Holdings Inc. (GDRX) PT Lowered to $4 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq hits near three-month low as Amazon, Intel rattle AI trade
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts GDRX Hot Sheet
Price: $3.44 -2.82%
Rating Summary:
11 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 48 | New: 9
Rating Summary:
11 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 48 | New: 9
Join SI Premium – FREE
UBS analyst Kevin Caliendo lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $4.00 (from $4.25) while maintaining a Neutral rating.
You May Also Be Interested In
- GoodRx Launches Employer Direct Weight Loss Offering
- Bright Horizons (BFAM) PT Lowered to $75 at BMO Capital
- Stryker (SYK) PT Lowered to $375 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
